Shire (SHP)

Share price graph

No market data available

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4758.50p Today's change: -1.07%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4758.50p 5 day change: N/A

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4758.50p 6 month change: +52.21%

Contact details

Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: www.shire.com

Company information

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

The board of Baxalta will come under renewed pressure to open takeover negotiations this week, following early [...]

10 August 2015
Views
253

Shares in pharma giant Shire recovered this morning after its $30bn (£19bn) hostile bid to take over US biotech [...]

5 August 2015
Shares
2
Views
184

London-listed pharma giant Shire has made a hostile approach for US rival Baxalta. [...]

4 August 2015
Shares
11
Views
708

ADHD drug-maker Shire is looking at a £12.4bn takeover of Europe’s biggest biotech company Actelion – just [...]

8 June 2015
Shares
18
Views
382

Drugs giant Shire traded up to three per cent higher yesterday morning and closed 0.95 per cent up, after news [...]

3 February 2015
Shares
7
Views
179

SHIRE’S $5.2bn (£3.45bn) takeover of NPS Pharmaceuticals just weeks ago is already paying off. Shire shares [...]

27 January 2015
Shares
5
Views
133

UK drugmaker Shire bounced back from its botched takeover by pharma giant AbbVie last night to seal a $5.2bn acquisition [...]

12 January 2015
Shares
9
Views
510

UK company Shire is to aquire with NPS Pharmaceuticals, according to a statement by the companies. [...]

11 January 2015
Shares
6
Views
250

Shire's share price soared this afternoon after the British pharma group posted strong quarterly results, increasing [...]

24 October 2014
Shares
2

The boss of US drugs giant AbbVie hit out at the “outdated” US tax regime after confirming the $55bn (£34bn) [...]

22 October 2014

Shire last night confirmed its $54bn (£32bn) deal with AbbVie was off, with a $1.635bn break fee owed.

21 October 2014
Shares
4

UK drugmaker Shire is eyeing up a number of acquisitions as it looks set to receive a windfall of as much as $1.6bn [...]

20 October 2014
Shares
6

Drug-maker Shire saw its share price tumble by a further 10 per cent yesterday, after US company AbbVie confirmed [...]

17 October 2014
Shares
1

The billion-pound deal between AbbVie and Shire could be over. [...]

16 October 2014
Shares
4

The fallout from US drug giant AbbVie’s decision late on Tuesday evening to reconsider its $54bn (£32bn) takeover [...]

16 October 2014
Shares
2

Content tagged with "Shire"